 |
| INFORMATION FOR AUTHORS |
 |
| EDITORS-IN-CHIEF |
| Edward B. Diethrich, MD, and Thomas J. Fogarty, MD |
| EDITORIAL OFFICE |
| Rebecca Bowman, Managing Editor |
| Journal of Endovascular Therapy |
| 1928 East Highland Avenue, #F104-605 |
| Phoenix, AZ 85016 USA |
| Telephone: 1-602-650-1331; Fax: 1-602-650-1345 |
| E-mail: editor@jevt.org |
|
|
| SCOPE AND CONTENT |
| The Journal of Endovascular Therapy (formerly the Journal of Endovascular Surgery), an official publication of the INTERNATIONAL SOCIETY OF ENDOVASCULAR SPECIALISTS (ISES), was established in 1994 as a forum for all physicians, scientists, and allied healthcare professionals who are engaged or interested in peripheral endovascular techniques and technology. The Journal seeks to support vascular specialists of all disciplines, improve patient care, and promote research and development by publishing peer-reviewed clinical and experimental studies and other materials related to the field of peripheral endovascular interventions. |
| The Journal will entertain original contributions, reviews, case reports, and technical notes on clinical or laboratory investigations of peripheral endoluminal therapies and research related to new endovascular technologies and techniques. At the discretion of the Editors, the Journal publishes editorials and letters and will designate especially timely or evolutionary articles as Rapid Communications or Works in Progress. Back to Top |
| EDITORIAL POLICIES |
|
Originality Materials submitted to the Journal must be original; they cannot have been previously published (other than as abstracts) nor can they be under simultaneous consideration by any other publication. If the work has been presented at a meeting or has been published as an abstract, a statement to this effect must appear on the title page, identifying the meeting, location, and date or details of the abstract publication. In general, manuscripts will not be considered if the work has been published in full-length conference proceedings or as a book chapter. Back to Top |
|
Authorship Responsibility All authors must have made a direct and substantial contribution to this work sufficient to take public responsibility for a meaningful share of its contents. At the request of the editors or their assignees, the authors may be required to produce for examination the data on which this manuscript is based. Statements affirming originality and authorship responsibility must be included in the submission letter. Back to Top |
|
Conflict of
Interest Disclosure Authors are obliged to disclose in the submission letter and on the title page of the manuscript any financial arrangement or other relationship that could be construed as a conflict of interest for any product mentioned in the manuscript. These arrangements include but are not limited to employment, direct payments, stock holdings, retainers, paid or unpaid consultancies, patents or patent licensing arrangements, research funding, speakers’ bureau, or honoraria with any individual, company, or organization having a vested interest in the subject matter or products mentioned in the manuscript. Declared relationships are not divulged to reviewers, but appropriately formatted statements will appear as a footnote on the first page on every published article, including editorials, commentaries, and correspondence. If the Editors believe or are notified that an author may have failed to make an appropriate disclosure, the author will be contacted. Depending upon the response, the Editors will decide if an erratum correcting the oversight should be published or if more serious action is warranted in the case of deception. In that event, the Editors may publish a notice that the author did not comply with the Journal’s requirement to disclose a conflict of interest, calling into question the reliability of the article. Back to Top |
|
Copyright Transfer Authors of articles, commentaries, editorials, and correspondence must agree in writing to transfer, assign, and convey all copyright ownership of their accepted materials to the INTERNATIONAL SOCIETY OF ENDOVASCULAR SPECIALISTS. Thus, manuscripts accepted for publication become the permanent property of the SOCIETY and may not be published elsewhere by the authors without written permission from the Journal. Manuscripts written by employees of the federal government during the course of their official duties may not be copyrightable. If an author falls under this designation, it should be appropriately noted in the submission letter. Electronic copies of the copyright documents are kept indefinitely. An individual may make a single photocopy of a published article for his or her personal use, but multiple copies cannot be made without the written permission of the Journal or from the Copyright Clearance Center. Back to Top |
|
Attestation All authors of accepted articles, commentaries, editorials, and correspondence are required to sign the Mandatory Conflict of Interest Disclosure, Copyright Transfer, and Author Responsibility Affirmations form, which is sent with the acceptance message and contains the following statements: ORIGINALITY: I warrant that this article is original in form and substance, contains no unlawful or libelous statements, and does not infringe on the rights of others. Furthermore, none of its material has been published previously in print, digital, or analogue media (except abstracts) or is under consideration for publication elsewhere. I have approved the final version of the manuscript, and I believe the facts it contains to be true. AUTHORSHIP RESPONSIBILITY: I have made a direct and substantial contribution to this work sufficient to take public responsibility for a meaningful share of its contents. If the editors or their assignees so request, I agree to produce for examination the data on which this manuscript is based. CONFLICT OF INTEREST: By checking “No” below, I attest that I have no association (including but not limited to employment, direct payments, stock holdings, retainers, paid or unpaid consultancies, patents or patent licensing arrangements, research funding, speakers’ bureau, or honoraria) with any individual, company, or organization with a vested interest in the subject matter/products mentioned in the manuscript. A check in the “Yes” box warrants that any conflict has been disclosed in the submission letter and manuscript or in a document returned with this form. COPYRIGHT TRANSFER: I transfer in perpetuity and throughout the world the copyright of this manuscript to the INTERNATIONAL SOCIETY OF ENDOVASCULAR SPECIALISTS. This transfer includes the right to reproduce all or part of the article in other media (including but not limited to digital and/or electronic files) for incorporation in computerized retrieval systems or other publication formats. This signed document must be returned to the Editorial Office before the material can be scheduled for publication. Back to Top |
|
Ethical and Animal
Experimentation Approval Studies involving human subjects or animal models must have the approval of the Institutional Review Board (IRB) or other agency responsible for human and/or animal research at the authors’ institution(s). Human subjects must have given written informed consent to the study in a document approved by the IRB or similar governing body. Experimental animals must have been cared for according to the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. Washington, DC: National Academy Press; 1996) or similar national guidelines. Statements certifying compliance with these requirements must appear in the Methods section of the manuscript. Back to Top |
|
Peer Review All manuscripts are reviewed initially by the Chief Editors and Managing Editor. A submission is rejected outright if the majority opinion finds that (1) the material does not have sufficient merit to warrant further review or (2) the subject matter is outside the scope of the Journal. The submission may also be returned for inadequate presentation or failure to comply with the Journal’s submission guidelines published in the Information for Authors. Manuscripts passing the initial evaluation will undergo blinded and anonymous review by two or more experts in the field. The identities of the authors are removed from the review version of the manuscript, and the names of the reviewers are never revealed to the authors. Reviewers are asked to give a confidential opinion on the importance, originality, and scientific merit of the manuscript and suggest changes that will improve the article. A formal statistical review may be obtained at the discretion of the Editors. The Editorial Office will relay via e-mail the final decision on the disposition of the manuscript to the corresponding author along with the reasons for the decision and, when appropriate, the comments from the reviewers. If revisions are requested, the authors are expected to revise the manuscript appropriately and promptly, clearly indicating the changes that have been made and/or explaining their differences of opinion with the reviewers’ comments. The Editorial Office will inform the reviewers of the final decision, accompanied by the comments of both reviewers. Back to Top |
|
Publication
and Reprints Accepted manuscripts will be scheduled for publication generally in the order in which they are received after no further author revisions are required and the Mandatory Conflict of Interest Disclosure, Copyright Transfer, and Author Responsibility Affirmations form has been received from all authors. The Journal reserves the right to edit accepted manuscripts to comply with the Journal’s format, to remove redundancies, to correct grammatical faults, and to improve readability without altering the meaning. Several weeks before the scheduled publication of an article, the edited version of the manuscript will be sent via e-mail to the corresponding author for approval. Within 3 weeks after the author returns the approved/corrected edited version, a PDF file of the page proof will be sent by e-mail for approval. At this stage, only correction of typographical errors or mistakes in the presentation of data can be made, provided the material is returned to the Editorial Office within 72 hours. Reprints will be furnished to authors when ordered in advance of publication and prepaid. An order form with price information will be sent to the author with the page proof. A complimentary PDF of the final article will be sent to the corresponding author after publication. Back to Top |
| MANUSCRIPT PREPARATION |
|
Manuscripts considered for publication must be written in English
and structured as a clinical or experimental investigation,
technical note, rapid communication, work in progress, editorial,
case report, review, or letter to the editors. Case reports may
contain individual case descriptions of up to 4 patients; 5 or more
cases constitute a series and are not presented as individual case
histories as a rule.
The Journal requires all materials to be submitted
electronically (no submissions accepted by mail); manuscripts
(except correspondence) must be accompanied by a submission
letter signed by all authors stating (1) there has been
no duplicate publication or submission of any part of the work; (2)
all authors have read and approved the manuscript; and (3) there is
no financial arrangement or other relationship that could be
construed as a conflict of interest. If a potential conflict exists,
its nature should be stated in the letter and on the title page of
the manuscript for each author involved (see Editorial Policies
for a complete explanation). Note: all correspondence from the
Editorial Office is sent by e-mail; no fax or mail delivery is used. Back to Top
Components of the Manuscript File Second-Level Head Third-level head.
Journal article: authors' names and initials, article title, journal name, year, volume, and inclusive page numbers. Example: Görich J, Rilinger N, Söldner J, et al. Endovascular repair of aortic aneurysms: treatment of complications. J Endovasc Surg. 1996;6:136-146. Abstracts (no more than 2 years old): authors' names and initials, title followed by [abstract], journal name, year, volume, and inclusive page numbers. Example: Reid DB, Diethrich EB. Intravascular ultrasound imaging in carotid artery stenting: results of a prospective study [abstract]. Cardiovasc Surg. 1996;4:661.
Checklist for Manuscript Submission
Originality: there has been no duplicate publication or submission of any part of the work (except abstracts),
 |